Urologix, Inc.
14405 21st Avenue North
Minneapolis,
MN 55447
United States - Map
Phone: 763-475-1400
Fax: 763-475-1443
Web Site: http://www.urologix.com
| Urologix, Inc. operates as a medical device company that engages in developing, manufacturing, and marketing non-surgical therapies to treat benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate. The companys core product is the Targis System, which consists of a Control Unit (sold under the Targis and CoolWave names) and a Microwave Catheter Procedure Kit (sold under the Cooled ThermoCath (CTC), CTC Advance, and Targis names). These products deliver the companys Cooled ThermoTherapy procedure, a branded transurethral microwave thermotherapy (TUMT) treatment, systematically. Its Cooled ThermoTherapy procedure relieves symptoms and obstruction of BPH by reducing enlarged prostate tissue. This system also enables physicians to customize treatment for individual patients through variable energy settings, while managing patient comfort. Urologix, Inc. sells its products to urologists through a mix of direct sales representatives and independent distributors in the United States and internationally. The company was founded in 1991 and is based in Minneapolis, Minnesota. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Mitchell Dann , 48
Co-Founder and Chairman |
$
26.00K |
$
29.00K | Mr. Stryker Warren Jr.,
Chief Exec. Officer |
$
298.00K |
$
0 | Ms. Rebecca J. Weber , 34
Principal Financial Officer, Principal Accounting Officer, Director of Fin. and Controller |
$
135.00K | N/A | Mr. Greg Fluet ,
Chief Operating Officer and Exec. VP |
$
174.00K | N/A | Ms. Jennifer Willner ,
Director of Regulatory and Quality |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
0.03 (2.63%) 
Profile
